Soc. Generale Call 14 GS7 16.09.2.../ DE000SD5TRJ8 /
5/19/2022 8:46:27 AM | Chg.-0.22 | Bid4:04:09 PM | Ask4:04:09 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.19EUR | -4.99% | 4.03 Bid Size: 10,000 |
4.06 Ask Size: 10,000 |
Glaxosmithkline PLC ... | 14.00 - | 9/16/2022 | Call |
GlobeNewswire
3/25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2/28
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...
GlobeNewswire
2/28
Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...
GlobeNewswire
2/10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
12/14/2021
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...